I igriot Mar 3, 2011 #1 Silicon Valley biotech firm InterMune climbed over six percent today after reporting that the European Commission approved its drug to treat a deadly lung disease. http://dock-of-bay.blogspot.com/p/silicon-valley-2.html
Silicon Valley biotech firm InterMune climbed over six percent today after reporting that the European Commission approved its drug to treat a deadly lung disease. http://dock-of-bay.blogspot.com/p/silicon-valley-2.html
N neutrosphere Mar 3, 2011 #2 itmn i got burned never again in this stock. was long got kill... at 10 bucks. then i shorted then it ripped to 38
itmn i got burned never again in this stock. was long got kill... at 10 bucks. then i shorted then it ripped to 38
S Stok Mar 3, 2011 #3 IPF killed my Dad...and there where NO real drugs/treatment until this. Hope it works out.